Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure
Scott D. Solomon, John W. Ostrominski, Xiaowen Wang, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 17, pp. 1587-1602
Open Access | Times Cited: 17

Showing 17 citing articles:

Preoperative Telerehabilitation Improves Outcomes After Cardiac Surgery
Subodh Verma, Makoto Mori, Mario Gaudino
Journal of the American College of Cardiology (2025) Vol. 85, Iss. 8, pp. 801-803
Closed Access | Times Cited: 1
Unlocking Therapeutic Potential for Cardiac Remodeling in Obesity-Related HFpEF
Khurram Nasir, Carlos Eduardo Rochitte
Journal of the American College of Cardiology (2025)
Closed Access | Times Cited: 1
Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction
Subodh Verma, Javed Butler, Barry A. Borlaug, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 17, pp. 1603-1614
Open Access | Times Cited: 11
Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure
Christopher M. Kramer, Barry A. Borlaug, Michael R Zile M, et al.
Journal of the American College of Cardiology (2024)
Open Access | Times Cited: 6
Incretin-based weight loss therapies and heart failure with preserved ejection fraction: guideline impactful results, but mechanisms unclear
Katarzyna Stefańska, Naveed Sattar
Cardiovascular Research (2025)
Closed Access
Advances in the management of obesity and heart failure: latest evidence from clinical trials
Thomaz Alexandre Costa, Josephine Harrington
Current Opinion in Cardiology (2025)
Closed Access
Update in Outpatient General Internal Medicine: Practice-Changing Evidence Published in 2024
Majken T. Wingo, Carl A Andersen, Nadir M Bhuiyan, et al.
The American Journal of Medicine (2025)
Closed Access
Intensive lifestyle intervention, cardiac biomarkers, and cardiovascular outcomes in diabetes: LookAHEAD cardiac biomarker ancillary study
Kershaw V. Patel, Zainali Chunawala, Subodh Verma, et al.
Journal of the American College of Cardiology (2024)
Closed Access | Times Cited: 2
Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets
Paschalis Karakasis, Panagiotis Theofilis, Panayotis K. Vlachakis, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 209-209
Open Access | Times Cited: 2
Six substudies from the semaglutide trials: Identifying mechanisms of benefit and whom to treat
Neha J. Pagidipati
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 17, pp. 1663-1665
Closed Access | Times Cited: 1
Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine
Riccardo M. Inciardi, Alvin Chandra, Ambarish Pandey, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 1
New and future heart failure drugs
Leila Haghighat, Colette DeJong, John R. Teerlink
Nature Cardiovascular Research (2024)
Closed Access | Times Cited: 1
GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction
Sumanth Khadke, Ashish Kumar, Ammar Bhatti, et al.
Journal of Cardiac Failure (2024)
Closed Access | Times Cited: 1
What's new in heart failure? October 2024
Matthew M.Y. Lee, Pau Codina, Daniela Tomasoni, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 10, pp. 2049-2054
Open Access
Avaliação do reposicionamento farmacológico da semaglutida no processo de emagrecimento: Uma revisão da literatura
Juliano Policarpio Moura, Filipe Tadeu Pereira Cintra, Lucas Raizama Obeid, et al.
Research Society and Development (2024) Vol. 13, Iss. 11, pp. e118131147305-e118131147305
Open Access
European Society of Cardiology Congress 2024 Meeting: Heart Failure Highlights
Elena Donald, Alexander Hajduczok, Patricia Campbell
Journal of Cardiac Failure (2024)
Closed Access
Actualización del posicionamiento sobre obesidad y enfermedad cardiovascular y renal de las Asociaciones de Cardiología Preventiva, Cardiología Clínica e Insuficiencia Cardiaca de la SEC
Almudena Castro Conde, Juan José Gorgojo Martínez, Nicolás Manito Lorite
REC CardioClinics (2024)
Closed Access
Page 1

Scroll to top